Medicines (Labelling of Chinese Proprietary Medicines) (Amendment) Regulations 2002

Status:

Published in Subsidiary Legislation Supplement
on 25 Oct 2002

No. S 557

Medicines Act

(Chapter 176)

Medicines (Labelling of Chinese Proprietary Medicines) (Amendment) Regulations 2002

In exercise of the powers conferred by section 44 of the Medicines Act, the Minister for Health hereby makes the following Regulations:

Citation and commencement

1. These Regulations may be cited as the Medicines (Labelling of Chinese Proprietary Medicines) (Amendment) Regulations 2002 and shall come into operation on 1st January 2003.

New regulation 9

2. The Medicines (Labelling of Chinese Proprietary Medicines) Regulations (Rg 13) are amended by inserting, immediately after regulation 8, the following regulation:

“Additional information to be shown on container, etc., of Chinese proprietary medicine

9.—(1) No person shall sell or supply any Chinese proprietary medicine unless it is labelled in accordance with this regulation —

(a)

with the following statement in English:

“Allowed for sale as a Chinese Proprietary Medicine”; and

(b)

with the following statement in Chinese:

(2) The statements specified in paragraph (1) shall be appended in the following manner:

(a)	where the Chinese proprietary medicine is or is intended to be sold or supplied by way of retail in a container without being enclosed in any other package, on that container;
(b)	where the Chinese proprietary medicine is or is intended to be sold or supplied by way of retail in a container which is immediately enclosed in a package, on that package; or
(c)	where the Chinese proprietary medicine is or is intended to be sold or supplied by way of retail packaged together with any other Chinese proprietary medicine (whether or not of the same type) so as to form a single unit, on the outermost package of that unit.

(3) Subject to paragraph (4), the statements specified in paragraph (1) —

(a)

shall be printed —

(i)	in the case of the statement in English, in a font size not less than 1.5 millimetres in height; and
(ii)	in the case of the statement in Chinese, in a font size not less than 2 millimetres in height;

(b)

shall be clearly legible;

(c)

shall be printed in an indelible manner;

(d)

shall appear conspicuously in a prominent position on the relevant container or package so as to be easily read by an intending purchaser or user of the Chinese proprietary medicine under normal conditions of purchase or use;

(e)

may appear together or separately; and

(f)

shall, wherever appearing, be in a boxed area which does not contain any other information or particulars.

(4) Notwithstanding paragraph (3)(a), the statements specified in paragraph (1) may be printed in a reduced font size where the relevant container or package is so small as to prevent the use of the relevant font size specified in paragraph (3)(a).

(5) For the purposes of paragraph (2) —

(a)	where a container is in the form of a bubble, blister or other sealed unit and is part of a continuous series comprising a sheet or strip of like containers, each sheet or strip of such containers by which the Chinese proprietary medicine is sold or supplied shall be treated as the container specified in paragraph (2)(a); and
(b)	where the package immediately enclosing a container referred to in sub-paragraph (a) is itself in the form of a bubble, blister or other sealed unit and is part of a continuous series comprising a sheet or strip of like packages, each sheet or strip of such packages by which the Chinese proprietary medicine is sold or supplied shall be treated as the package specified in paragraph (2)(b).”.

Made this 18th day of October 2002.

MOSES LEE

Permanent Secretary,
Ministry of Health,
Singapore.

[CPA(CPM)6:04/1; AG/LEG/SL/176/2002/1 Vol. 1]

Search within Legislation